Action Alturas Minerals - ALT

Alturas Minerals Corp (ALT) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,015

( - )

Prix Achat

0,01

Prix Vente

0,015

Volume échangé

0,00 Fourchette du Jour 0,00

0,005 Plage de 52 semaines 0,015

Cap du marché

2,184M

Clôture Veille

0,015

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

$ 230 667

Actions en circulation

145 632 143

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-8,46

Bénéfice par action (BPA)

-0

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-124,74k

Alturas Minerals Corp., together with its subsidiaries, focuses on the exploration and development of mineral properties in Peru and Chile. It explores for copper-gold porphyry/skarn deposits and epithermal gold mineralized deposits. The company’s projects include Resguardo Copper-Gold Project locat... Alturas Minerals Corp., together with its subsidiaries, focuses on the exploration and development of mineral properties in Peru and Chile. It explores for copper-gold porphyry/skarn deposits and epithermal gold mineralized deposits. The company’s projects include Resguardo Copper-Gold Project located in northeast of Copiapó, northern Chile; and Copperlode Property. The company is based in Toronto, Canada. Show more

Secteur

Materials

Industrie

Mining

Site Web

www.alturasminerals.com

Siège social

Toronto, Canada

Fondé

Alturas Minerals Corp est coté dans le secteur Materials de la TSX Venture Exchange avec le ticker ALT. Le dernier cours de clôture d'Alturas Minerals était de $0,02. Au cours de la dernière année, les actions de Alturas Minerals ont été négociées dans une fourchette de prix de $ 0,005 à $ 0,015.

Alturas Minerals compte actuellement 145 632 143 actions en circulation. La capitalisation boursière d'Alturas Minerals est de $2,18 million. Alturas Minerals a un ratio cours/bénéfice (ratio PE) de -8.46.

/C O R R E C T I O N -- Alteon, Inc./

In the news release, Alteon Signs Agreements for Sale of Approximately $1.4 Million in Common Stock PIPE Transaction, issued earlier today by...

Alteon Updates Investors on Alagebrium Development Status

Alteon Updates Investors on Alagebrium Development Status - Alagebrium Preclinical Toxicity Tests Progressing; Company Intends to Perform SPECTRA...

Alteon Announces Year-End and Fourth Quarter Results

Alteon Announces Year-End and Fourth Quarter Results PARSIPPANY, N.J., March 15 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced...

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction - 'EMERALD' Trial to Test the Efficacy of Alagebrium in Diabetic Men...

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004 PARSIPPANY, N.J., Nov. 11...

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diab

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diabetes PARSIPPANY...

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypert

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypertension Meeting...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.005	50	0.01	0.015	0.01	4280	0.01499977	CS
4	0	0	0.015	0.015	0.01	99251	0.0149939	CS
12	0.01	200	0.005	0.015	0.005	125233	0.01181991	CS
26	0.01	200	0.005	0.015	0.005	88381	0.01078916	CS
52	0.005	50	0.01	0.015	0.005	67435	0.00929827	CS
156	-0.005	-25	0.02	0.02	0.005	32575	0.0084553	CS
260	-0.02	-57.1428571429	0.035	0.035	0.005	24745	0.01138373	CS

ALT - Frequently Asked Questions (FAQ)

What is the current Alturas Minerals Corp share price?

The current share price of Alturas Minerals Corp is $ 0,015

How many Alturas Minerals Corp shares are in issue?

Alturas Minerals Corp has 145 632 143 shares in issue

What is the market cap of Alturas Minerals Corp?

The market capitalisation of Alturas Minerals Corp is CAD 2,18M

What is the 1 year trading range for Alturas Minerals Corp share price?

Alturas Minerals Corp has traded in the range of $ 0,005 to $ 0,015 during the past year

What is the PE ratio of Alturas Minerals Corp?

The price to earnings ratio of Alturas Minerals Corp is -8,46

What is the registered address of Alturas Minerals Corp?

The registered address for Alturas Minerals Corp is 372 Bay Street, Toronto, Ontario, M5H 2W9

What is the Alturas Minerals Corp website address?

The website address for Alturas Minerals Corp is www.alturasminerals.com

Which industry sector does Alturas Minerals Corp operate in?

Alturas Minerals Corp operates in the Mining sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Alturas Minerals Corp (ALT)

Alturas Minerals Corp (ALT) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Alturas Minerals Corp

ALT Dernières nouvelles

/C O R R E C T I O N -- Alteon, Inc./

Alteon Updates Investors on Alagebrium Development Status

Alteon Announces Year-End and Fourth Quarter Results

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diab

Alteon to Change Principal Accountants

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D.

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypert

ALT - Frequently Asked Questions (FAQ)

ALT Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Alturas Minerals Corp (ALT)

Alturas Minerals Corp (ALT) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Alturas Minerals Corp

ALT Dernières nouvelles

/C O R R E C T I O N -- Alteon, Inc./

Alteon Updates Investors on Alagebrium Development Status

Alteon Announces Year-End and Fourth Quarter Results

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diab

Alteon to Change Principal Accountants

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D.

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypert

ALT - Frequently Asked Questions (FAQ)

ALT Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Inscrivez-vous GRATUITEMENT et obtenez:

Supprimer les publicités